Man Group’s Agilon Health AGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-9,491
Closed -$1.45M 2010
2024
Q1
$1.45M Buy
+9,491
New +$1.58M ﹤0.01% 1419
2023
Q3
Sell
-4,613
Closed -$2M 1900
2023
Q2
$2M Buy
+4,613
New +$2.59M 0.01% 1198
2023
Q1
Hold
0
1173
2022
Q2
Hold
0
902
2021
Q4
Sell
-596
Closed -$391K 1933
2021
Q3
$391K Buy
596
+162
+37% +$138K ﹤0.01% 1591
2021
Q2
$440K Buy
+434
New +$380K ﹤0.01% 1599

Other funds holding AGL

Man Group's AGL Position: Q2 2024 in Review

Man Group sold out of Agilon Health (AGL) in Q2 2024, closing a stake of 9,491 shares — an estimated $1.45M sold.

Man Group first reported a position in AGL in Q2 2021 and held it in 4 quarters. The position peaked at $2M in Q2 2023. 201 funds tracked by Wall St. Rank hold AGL as of Q2 2024.

  • Man Group reported no remaining Agilon Health position as of Q2 2024 after selling out during the quarter.
  • Man Group sold 9,491 Agilon Health shares in Q2 2024, an estimated $1.45M.
  • Man Group first reported a position in Agilon Health in Q2 2021 and held it in 4 quarters.
  • Man Group's Agilon Health position peaked at $2M in Q2 2023.
  • 201 funds tracked by Wall St. Rank held Agilon Health as of Q2 2024.

Based on Man Group's 13F filing for Q2 2024, filed 14 Aug 2024.